--South Africa's Competition Commission gave conditional approval to a proposed joint venture between pharmaceutical companies GlaxoSmithKline PLC (GSK) and Pfizer Inc. (PFE), Reuters reported Tuesday.

--The Commission suggested the JV continue to use South African manufacturer and packager Spechparm Holdings for three years, in an effort to alleviate the impact of the deal on local companies working for Pfizer, the report said.

Full story: https://www.reuters.com/article/us-pfizer-gsk-jointventure/gsk-pfizer-joint-venture-gets-conditional-approval-from-south-africas-competition-regulator-idUSKCN1TX1MR

--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

(END) Dow Jones Newswires

July 02, 2019 13:55 ET (17:55 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Gsk.
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Gsk.